MESA ROYALTY TRUST/TX (MTR): Results of Operations and Financial Condition

MESA ROYALTY TRUST/TX (MTR) filed an SEC Form 8-K — Results of Operations and Financial Condition. 8-K 1 tm2620765d1_8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 20, 2026 Mesa Royalty Tr

MESA ROYALTY TRUST/TX (MTR) filed an SEC Form 8-K — Results of Operations and Financial Condition. 8-K 1 tm2618084d1_8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2026 Mesa Royalty Tr

Lumentum Holdings (LITE) reported fiscal Q4 revenue of $1B, up 109% YoY, with adjusted EPS at $3.23. Guidance for Q1 suggests 134% YoY revenue growth to $1.25B. NVIDIA invested $2B in Lumentum for optical components crucial for AI data centers, highlighting supply-demand imbalances. Analysts predict strong growth but note risks like AI spending slowdowns.

KE Holdings (BEKE) reported Q2 2026 results with GTV up 6.3% YoY, non-GAAP net income up 74.9% YoY to RMB 3.2B, and gross margin at 28.6%. Revenue declined in home renovation and rental but improved in existing and new home segments. The company repurchased $250M in shares and maintained a cash balance of RMB 67.3B. Management highlighted cost optimizations and strategic shifts.

Horizon Kinetics Holding Corp (HKHC) reported a Q2 2026 net loss of $18.4M, or $0.99 per share, due to unrealized investment losses. Revenues from mutual funds fell 17% YoY, while operating expenses rose 5.5%. AUM dropped to $10.8B, impacted by declines in TPL and bitcoin-related holdings. The company plans to launch targeted marketing for ETFs and invest in AI data center resources. GAAP net income for H1 2026 was $54.2M, boosted by Q1 performance fees.

ARS Pharma (SPRY) reported Q2 2026 U.S. net product revenue of $26.2M, with total market share reaching 5%, up from 2.5% YoY. Neffy's market share in targeted areas hit 8%, driven by 16,000+ unique prescribers. The company aims to expand into the CSU market and expects cash flow breakeven by late 2027. Total revenue was $33.7M, with operating expenses at $95.1M. ARS plans to reduce SG&A and R&D expenses by over 40% in the second half of 2026.